Jane Agergaard

Myopathy as a cause of fatigue in long‐term <scp>post‐COVID</scp>‐19 symptoms: Evidence of skeletal muscle histopathology

Eva Kildall Hejbøl, Thomas Harbo, Jane Agergaard et al. · European Journal of Neurology · 2022 · 114 citations · Full text

Medicine, Pathobiology, Pathology +16

Myopathic changes in patients with long-term fatigue after COVID-19

Jane Agergaard, Steffen Leth, Thomas Holm Pedersen et al. · Clinical Neurophysiology · 2021 · 95 citations · Full text

Medicine, Internal Medicine, Neurology +17

Persistent Symptoms in Patients Recovering From COVID-19 in Denmark

Steffen Leth, Jesper Damsgaard Gunst, Kristoffer Skaalum Hansen et al. · Open Forum Infectious Diseases · 2021 · 64 citations · Full text

Nursing, Infectious Diseases, Internal Medicine +10

High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial

Kristoffer Skaalum Hansen, Trine H. Mogensen, Jane Agergaard et al. · The Lancet Regional Health - Europe · 2022 · 52 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +9

Diphtheria–tetanus–pertussis vaccine administered simultaneously with measles vaccine is associated with increased morbidity and poor growth in girls. A randomised trial from Guinea-Bissau

Jane Agergaard, Ernesto Nante, G. Poulstrup et al. · Vaccine · 2010 · 35 citations

Medicine, Child Health, Pediatrics +15